About Ankur Drugs and Pharma Limited
Data last updated:
Ankur Drugs and Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 February 1995.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24230MH1995PLC085410. It is recorded as listed by MCA, but its shares were delisted from NSE on 12 May 2017 · winding up and from BSE on 23 Aug 2017 · compulsory delisting, and no longer trade on a stock exchange.
The company has an authorised share capital of ₹28 Cr and a paid-up capital of ₹19.34 Cr. It is led by directors including Purnandu Shekharmal Jain (Managing Director) and Girraj Moolchand Vijayvargiya (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2011, and its latest financial statements are for the year ended 31 March 2011. The registered office is at C – 306 Crystal Plaza Andheri Link Road Andheri (West), Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2012, the company reported a revenue of ₹151.68 Cr, a decline of 82% compared to the previous year.
The company has about 101 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ankur Drugs. As per MCA filings, the company has open charges of ₹2,253.69 Cr on record. Court records list 511 cases involving the company, including 53 filed by the company and 458 filed against it; 60 cases are pending. The company has 32 deals on record (30 market trades, 1 secondary share transfer, 1 funding round), with disclosed funding of ₹20.95 Cr; the latest was in May 2011. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Combitic Global Caplet Private Limited with revenue of ₹154.55 Cr.
The last known website on record is ankurdrugs.com.
Company details
Contact details
Ankur Drugs and Pharma Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressC – 306 Crystal Plaza Andheri Link Road Andheri (West), Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ankur Drugs and Pharma operates one associated brand: Ankur Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| CMO specializing in cephalosporins and beta-lactams | ankurdrugs.com |
Financials of Ankur Drugs and Pharma Limited
FY 2011 filings availableAnkur Drugs and Pharma Limited reported revenue of ₹151.68 Cr (down 82% YoY) for FY 2012.
Compounded Annual Growth Rate (CAGR)
Revenue fell 82% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2011-12 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2011-12 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Ankur Drugs and Pharma Limited, buy the company report.
Board of directors and KMP of Ankur Drugs and Pharma Limited
Ankur Drugs and Pharma Limited currently reports 4 directors and 1 key managerial person. 5 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dileep Himmatrao Shinde Also directs: Balkrishna Paper Mills Limited | Director | 31 Aug 2004 | 22 Years 2 Months | As last reported |
| Ramesh Balaram Batham | Director | 14 Oct 2010 | 16 Years 0 Months | As last reported |
| Purnandu Shekharmal Jain | Managing Director | 15 Oct 1996 | 30 Years 0 Months | As last reported |
| Girraj Moolchand Vijayvargiya | Whole-Time Director | 02 Apr 2006 | 20 Years 7 Months | As last reported |
| Sanjay Chandrasen Rane | Company Secretary | 01 Aug 2005 | 21 Years 3 Months | As last reported |
Peer comparison
Ankur Drugs and Pharma Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Combitic Global Caplet Private Limited | ₹154.55 Cr (FY 2025) | 37.0% | New Delhi, Delhi, India | |||
| Medico Remedies Limited | ₹153.63 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Sanzyme Private Limited | ₹153.25 Cr (FY 2025) | -27.0% | Hyderabad, Telangana, India | |||
| D K Pharma Chem Private Limited | ₹153.13 Cr (FY 2024) | -33.0% | Badlapur, Maharashtra, India | |||
| Hema Laboratories Pvt Ltd | ₹152.89 Cr (FY 2025) | 0.0% | Wadhwancity, Gujarat, India | |||
| Ankur Drugs and Pharma Limitedthis company | ₹151.68 Cr (FY 2012) | -82.0% | Mumbai, Maharashtra, India | |||
| PRG Pharma Private Limited | ₹150.93 Cr (FY 2025) | -13.0% | Chandigarh, India | |||
| Oswal Marketing Jabalpur Private Limited | ₹150.92 Cr (FY 2025) | 17.0% | Jabalpur, Madhya Pradesh, India | |||
| Themis Distributors Private Limited | ₹149.94 Cr (FY 2025) | 76.0% | Mumbai, Maharashtra, India | |||
| Leben Laboratories Private Limited | ₹149.37 Cr (FY 2025) | 15.0% | Akola, Maharashtra, India | |||
| Zydus Pharmaceuticals Limited | ₹148.75 Cr (FY 2025) | 110.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Ankur Drugs and Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 May 2012 | 10358540 | Ifci Factors Limited | ₹5 Cr | Open | |
| 13 Jul 2011 | 10298741 | The Shamrao Vithal Co-Operative Bank Limited | ₹8.85 Cr | Open | |
| 09 Jun 2011 | 10298748 | Indusind Bank Ltd. | ₹8 Cr | Open | |
| 10 Feb 2011 | 10271961 | The Shamrao Vithal Co-Operative Bank Ltd. | ₹3.5 Cr | Open | |
| 17 Jan 2011 | 10273344 | Ifci Factors Limited | ₹15 Cr | Open |
To see the full charge records of Ankur Drugs and Pharma Limited, buy the company report.
Total charge records: 72 View all charges
Deals & funding
Ankur Drugs and Pharma Limited has 32 deals on record (30 market trades, 1 secondary share transfer, 1 funding round), with disclosed funding of ₹20.95 Cr; the latest was in May 2011.
Deals on record (5 of 32)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2010 | Market trade | ₹3.06 Cr | Buyer: RKSV Securities India Private Limited Seller: Apna Ghar Hsg Development Finance Limited, RKSV Securities India Private Limited |
| Aug 2010 | Market trade | ₹2.95 Cr | Buyer: Privatbank Ihag Zurich Ag Seller: Karvy Financial Services Limited |
| Nov 2005 | Market trade | ₹2.1 Cr | Buyer: Bhavani Portfolio Private Seller: Tater Fin-Vest Private Limited , an individual |
| Apr 2005 | Market trade | ₹1.08 Cr | Buyer: Shalimar Pellet Feeds Limited. , an individual |
| Jan 2005 | Market trade | ₹42.8 Lakh | Seller: Maruti Global Industries Limited |
To see the full deal history of Ankur Drugs and Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ankur Drugs and Pharma Limited has 511 court cases on record: 53 filed by Ankur Drugs and Pharma, 458 filed against it. 60 cases are pending and 451 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 395 | 383 | 52 |
| High courts | 113 | 74 | 8 |
| Supreme Court | 3 | 1 | 0 |
Cases on record (5 of 511)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, Rajasthan | Court case (CFA) | Filed against the company by Nikom Pharmaceutical Pvt. Ltd. | Pending |
| District court, Central, Delhi | Criminal case | Filed against the company by Bry Air Asia Pvt.Ltd | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Edelweiss Asset Reconstruction Company Limited | Disposed |
| High Court, MAHARASHTRA | Court case (OLR) | Filed by the company against Canbank Factors Limited. (Petitioner) and 8 others | Disposed |
| Bombay High Court | Appeal | Filed against the company by Cipla Health Limited | Disposed |
To see the full case history of Ankur Drugs and Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ankur Drugs and Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ankur Drugs and Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ankur Drugs and Pharma Limited has 13 board changes on record since 1996: 9 appointments and 4 cessations. The latest: Anilkumar Khadke ceased to be Nominee Director on 15 Mar 2013.
96 earlier events are in the company report.
Frequently asked questions
Ankur Drugs and Pharma is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Ankur Drugs and Pharma is a company under liquidation, formerly operating as a public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 February 1995 and is registered under CIN L24230MH1995PLC085410. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Ankur Drugs and Pharma has 5 current directors and KMP:
- Purnandu Shekharmal Jain - Managing Director
- Girraj Moolchand Vijayvargiya - Whole-Time Director
- Dileep Himmatrao Shinde - Director
- Ramesh Balaram Batham - Director
- Sanjay Chandrasen Rane - Company Secretary
The latest financial statements of Ankur Drugs and Pharma on record with the MCA are for the year ended 31 March 2011. Its last annual general meeting was held on 30 September 2011. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Ankur Drugs and Pharma is L24230MH1995PLC085410. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ankur Drugs and Pharma is recorded as a listed company by MCA, but its shares were delisted from NSE on 12 May 2017 · winding up and from BSE on 23 Aug 2017 · compulsory delisting, and no longer trade on a stock exchange.
Ankur Drugs and Pharma has open charges of ₹2,253.69 Cr and no satisfied charges on record as per latest MCA filings.
Ankur Drugs and Pharma has 511 court cases on record: 53 filed by the company and 458 filed against it. 60 are pending. Most are in the district courts.
Ankur Drugs and Pharma was incorporated on 09 February 1995. It is registered with the Registrar of Companies, Mumbai.
Ankur Drugs and Pharma has 32 deals on record (30 market trades, 1 secondary share transfer, 1 funding round), with disclosed funding of ₹20.95 Cr; the latest was in May 2011.
The peers of Ankur Drugs and Pharma by revenue are Combitic Global Caplet Private Limited, Medico Remedies Limited, Sanzyme Private Limited, D K Pharma Chem Private Limited, Hema Laboratories Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
